Company intelligence
Arclio
FDA-defensible answers from your trial data
About Arclio
Arclio is a clinical-evidence platform for biopharma. It gives regulatory, clinical, and biostatistics teams FDA-defensible answers from their trial data in 30 seconds, not three days. Unlike tools that only show where a number came from, Arclio proves it correct and unaltered through deterministic, re-runnable computations on a tamper-evident evidence chain. The agent runs entirely inside your own infrastructure — no data ever moves. It produces publication-grade charts and an FDA readiness scorecard across efficacy, safety, data quality, competitive positioning, and biomarkers.
Verified activity
Signals from Arclio
2 published signals
Products & Services
Arclio ran a walkthrough for a clinical ops lead evaluating the company's site logs and protocol deviations.
Reported by Jacques Kotze
Products & Services
Arclio showed the receipts of clinical study reports, demonstrating the evidence chain behind every value in a clinical study report, one click from source.
Reported by Jacques Kotze